NO972522L - Monoklonale antistoffer med immunoundertrykkende aktivitet - Google Patents

Monoklonale antistoffer med immunoundertrykkende aktivitet

Info

Publication number
NO972522L
NO972522L NO972522A NO972522A NO972522L NO 972522 L NO972522 L NO 972522L NO 972522 A NO972522 A NO 972522A NO 972522 A NO972522 A NO 972522A NO 972522 L NO972522 L NO 972522L
Authority
NO
Norway
Prior art keywords
fragments
mab
monoclonal antibodies
fab
immunosuppressive activity
Prior art date
Application number
NO972522A
Other languages
English (en)
Norwegian (no)
Other versions
NO972522D0 (no
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972522D0 publication Critical patent/NO972522D0/no
Publication of NO972522L publication Critical patent/NO972522L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO972522A 1994-12-07 1997-06-03 Monoklonale antistoffer med immunoundertrykkende aktivitet NO972522L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07
PCT/EP1995/004648 WO1996017874A1 (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments having immunosuppressant activity

Publications (2)

Publication Number Publication Date
NO972522D0 NO972522D0 (no) 1997-06-03
NO972522L true NO972522L (no) 1997-08-06

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972522A NO972522L (no) 1994-12-07 1997-06-03 Monoklonale antistoffer med immunoundertrykkende aktivitet

Country Status (19)

Country Link
EP (1) EP0787151A1 (pt)
JP (1) JP2001506122A (pt)
CN (1) CN1168679A (pt)
AR (1) AR002005A1 (pt)
AU (1) AU4256096A (pt)
BR (1) BR9509902A (pt)
CA (1) CA2206471A1 (pt)
CO (1) CO4480041A1 (pt)
CZ (1) CZ172497A3 (pt)
FI (1) FI972430A7 (pt)
HU (1) HUT77342A (pt)
IL (1) IL116228A0 (pt)
MA (1) MA23739A1 (pt)
NO (1) NO972522L (pt)
PE (1) PE52996A1 (pt)
PL (1) PL320610A1 (pt)
TR (1) TR199501542A2 (pt)
WO (1) WO1996017874A1 (pt)
ZA (1) ZA9510195B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
AU5588099A (en) 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
ATE365749T1 (de) * 2000-05-12 2007-07-15 Gpc Biotech Ag Humane peptide/proteine, die das töten von zellen,einschliesslich lymphoide tumorzellen, herbeiführen oder bewirken
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
US20030086929A1 (en) 2001-10-11 2003-05-08 Tso J. Yun Treatment of prostate cancer by inhibitors of ATP synthase
EP1369431A4 (en) 2001-10-15 2005-01-12 Kirin Brewery ANTI-HLA-DR ANTIBODIES
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2552483A4 (en) * 2010-04-01 2013-09-25 Immunomedics Inc USE OF ANTIBODIES TO REDUCE THE NUMBER OF CELLS CONTAINING ANTIGENS AND DENDRITIC CELLS
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
JPH05502586A (ja) * 1989-12-27 1993-05-13 セントカー・インコーポレーテツド Ｃｄ４受容体に対するキメラ免疫グロブリン
NZ243706A (en) * 1991-07-25 1994-08-26 Idec Pharma Corp Recombinant monkey antibodies, pharmaceutical compositions

Also Published As

Publication number Publication date
IL116228A0 (en) 1996-03-31
MX9704225A (es) 1997-09-30
TR199501542A2 (tr) 1996-07-21
BR9509902A (pt) 1997-10-21
FI972430L (fi) 1997-06-06
PL320610A1 (en) 1997-10-13
AR002005A1 (es) 1998-01-07
PE52996A1 (es) 1996-12-12
ZA9510195B (en) 1996-06-07
EP0787151A1 (en) 1997-08-06
CO4480041A1 (es) 1997-07-09
CZ172497A3 (en) 1997-10-15
MA23739A1 (fr) 1996-07-01
WO1996017874A1 (en) 1996-06-13
FI972430A0 (fi) 1997-06-06
FI972430A7 (fi) 1997-06-06
NO972522D0 (no) 1997-06-03
AU4256096A (en) 1996-06-26
CA2206471A1 (en) 1996-06-13
CN1168679A (zh) 1997-12-24
HUT77342A (hu) 1998-03-30
JP2001506122A (ja) 2001-05-15

Similar Documents

Publication Publication Date Title
DE69429095D1 (de) Humanisierte antikoerper
WO1998057994A3 (en) Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
GR3036906T3 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof.
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
DK0673418T3 (da) Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig
ATE263189T1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
BR9713521A (pt)
EP0677533A3 (en) Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
CA2212150A1 (en) Monoclonal antibodies for human osteogenic cell surface antigens
DK0969873T3 (da) Multiple carbonhydratholdige glycopeptid-antigener, vaccine indeholdende dem og anvendelse deraf
DK0845998T3 (da) Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
CA2137638A1 (en) Anti Gangliosides Monoclonal Antibodies and Their Use in the Specific Active Immunotherapy of Malignant Tumors
GR3029483T3 (en) Antibodies against t-cells as therapeutics
CA2036814A1 (en) Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof
ES2119992T3 (es) Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt).
WO2000001729A3 (en) Synthetic peptides and pharmaceutical compositions comprising them for diagnosis and treatment of anti-phospholipid syndrome
PL314414A1 (en) Antiidiotypic antibodies capable to induce an immunological response in respect to the receptor of epidermis growth factor
NO962827D0 (no) Monoklonale antistoffer mot antigener uttrykt av hematopoietider facilitatoriske celler
BR9702101A (pt) Hibridoma e anticorpo monoclonal
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
ECSP951605A (es) Fragmentos de anticuerpos monoclonales que tienen actividad inmunosupresora, case ran 4105/171
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
刘亚霞 et al. ISOLATION AND STUDY OF THE CD2 ANTIGEN PURIFIED BY AFFINITY CHROMATOGRAPHY WITH OKT11-LIKE MAB
ES2088820A1 (es) Anticuerpos monoclonales antineumolisina.